pharmacogenomics clinic
decades discovery inherited variations identified approximately genes affect medications actionable clinic somatically acquired genetic variants direct choice targeted anticancer drugs individual patients current efforts focus processes required appropriately act pharmacogenomic variability clinic moving away discovery towards implementation evidenced-based strategy improving use medications thereby providing cornerstone precision medicine
